{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/a4c5de36-8260-4222-8e38-ff997dc73436/63249e1b6042d80013290975?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Companies & Markets Show: ITM Power, Trussonomics and the challenges for UK healthcare and biotechs","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9b44742e856e989985776/1663343921327-a8e54a2c1a111814976f91d834e459a0.jpeg?height=200","description":"<p>On this week's Companies and Markets show, the team discuss a reality check for hydrogen hope&nbsp;<strong>ITM Power (ITM)</strong>, whose&nbsp;<a href=\"https://www.investorschronicle.co.uk/news/2022/09/14/itm-powers-down/\" rel=\"noopener noreferrer\" target=\"_blank\">annual results sparked a steep sell-off in the company’s shares on Wednesday</a>.</p><p><br></p><p>Economics writer Hermione Taylor then outlines<a href=\"https://www.investorschronicle.co.uk/news/2022/09/09/will-trussonomics-avert-a-uk-recession/\" rel=\"noopener noreferrer\" target=\"_blank\">&nbsp;the debate over ‘Trussonomics’</a>, looking at government policies and their potential impact on the UK economy, sterling, and the gilt market.</p><p><br></p><p>Last but not least, Jennifer Johnson runs the rule over<a href=\"https://www.investorschronicle.co.uk/news/2022/09/14/no-rapid-recovery-at-advanced-medical-solutions/\" rel=\"noopener noreferrer\" target=\"_blank\">&nbsp;latest figures from&nbsp;<strong>Advanced Medical Solutions (AMS)</strong></a>&nbsp;and&nbsp;<a href=\"https://www.investorschronicle.co.uk/news/2022/09/12/abcam-ready-to-reap-benefits-of-investment-drive/\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>Abcam (ABC)</strong></a>, as well as the latter’s plans to delist from Aim.</p><p><br></p><p>Dan Jones hosts Julian Hofmann, Hermione Taylor, Jennifer Johnson and Alex Newman.</p>","author_name":"Investors' Chronicle"}